Rest Innovations is commercializing a novel injectable or implantable agent for the immediate treatment of snoring and sleep apnea. The core patented technology has been previously developed for human spinal disorders and is sold by a sister company as a treatment for horse tendon and ligament injuries. The potential market is massive: snoring affects 48% of men and 34% of women. Sleep apnea affects 10 million in the US alone.